Precigen (PGEN) Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization
Precigen, Inc. (PGEN) aims to optimize gene therapy delivery through express production within clinics. The EV/EBITDA multiple on the time chart confirms this potential, with the indicator standing at 43.73. However, sanctions are limiting global research, and the high cost of developing new platforms creates a dependency on external investments, which heightens the company's financial risks.
precigen.com - analytical breakdowns and key metrics (PGEN)
- current price and projected stock value:
- market capitalization details:
- book value of equity indicators:
- debt level and financial liquidity data:
- business earnings and investment ratios data:
PGEN - Company Net Income|Projected Future Earnings Precigen, Inc.|PGEN - Price to Earnings Ratio|Forward P/E Multiple Precigen, Inc.|PGEN - Growth-Adjusted Market Cap to Net Income|EV/EBITDA Multiple Precigen Corp|PGEN - Operating profit before depreciation charges|Net earnings per share (EPS TTM) Precigen|PGEN - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months precigen.com|PGEN - Earnings per share growth this year|Expected earnings per share growth for next year Precigen, Inc.
Initial company analysis:PGEN (Intrexon)
To assess the long-term risks of Precigen, Inc. (PGEN), it is critical to monitor the Enterprise Value to EBITDA (EV/EBITDA) ratio, which measures debt coverage efficiency and capitalization via current cash flow. By analyzing the historical EV/EBITDA ratio of the business, an investor can see how high R&D expenses and expectations for success in gene therapy influence the company's valuation, which is already priced into the stock quotes.
Direct competitors
EV/EBITDA Multiple ARGX (Argenx)|Total Company Value to Operating Income Before Depreciation Ratio BioNTech Pharma (BNTX)|ABVX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|admabiologics.com (ADMA) - Enterprise Value to EBITDA Ratio|Protagonist (PTGX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Immunovant Inc|Enterprise Value to EBITDA Ratio KNSA|EV/EBITDA Multiple Grifols Biemat|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Adaptive Biotechnologies (ADPT)|celldex.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple AUPH (Aurinia Pharmaceuticals Inc.)|BioCryst Pharmaceuticals, Inc. (BCRX) - Company Value to EBITDA|VERA - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio DNTH|Pharvaris N.V. (PHVS) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|AbCellera - Business Value to Operating Income Before Depreciation|TRML (Tourmaline Bio) - EV/EBITDA Multiple|Company Value to EBITDA Pharming Group NV PHAR|EV/EBITDA Multiple NKTR|Enterprise Value to EBITDA Ratio Upstream Pharma UPB|EV/EBITDA Multiple ZBIO (Zenas Biopharma Inc)|Total Company Value to Operating Income Before Depreciation Ratio immunome.com (IMNM)|Gossamer Bio - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple KalVista Pharma (KALV)|SEPN: EV/EBITDA Multiple|Company Value to EBITDA Pieris Corp (PVLA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Savara Inc.|Enterprise Value to Operating Income Before Depreciation RIGL (rigel.com)|Enterprise Value to EBITDA Ratio ANAB (AnaptysBio)|ATXS (Astria Therapeutics Inc) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple ENGN (enGene Bio)|Total Company Value to Operating Income Before Depreciation Ratio rapt.com (RAPT)|JBIO - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|ACRS (aclaristx.com) - Enterprise Value to Operating Income Before Depreciation|KYTX: EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio Tiziana Life Sciences Ltd.|Enterprise Value to EBITDA Ratio CABA|Ventyx Biosciences, Inc (VTYX) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Theratechnologies Inc. (THTX)|AVTX: Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple ELDN (Eledon Pharmaceuticals, Inc.)|Enterprise Value to EBITDA Multiple Agenus, Inc.|Climb Bio, Inc. - EV/EBITDA Multiple|Company Value to EBITDA zurabio.com|aTyr Pharma, Inc. (ATYR) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to Operating Income Before Depreciation ADAG|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization ImageneBio|Shattuck Therapeutics - Company Value to Operating Income Before Depreciation Ratio|EV/EBITDA Multiple EQ|CNTB (connectbiopharm.com) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple IMUX (Immunic)|EV/EBITDA Multiple Atara Biotherapeutics, Inc. ATRA|IFRX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Business Value to Operating Income Before Depreciation XFOR (X4 Pharmaceuticals Inc.)|adicetbio.com (ACET) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio Celularity|INMB (INmune Bio, Inc.) - EV/EBITDA Multiple|EV/EBITDA Multiple barinthusbio.com|Enterprise Value to EBITDA Ratio KZR (Kezar Life Sciences, Inc.)|SABS (SAB Biotherapeutics Inc.) - Business Value to Operating Income Before Depreciation|EV/EBITDA Multiple AKTX (Akari Therapeutics plc)|Total Company Value to Operating Income Before Depreciation Ratio Enlivex Therapeutics Ltd (ENLV)|QTTB - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|geovax.com (GOVX) - Enterprise Value to EBITDA Ratio|Edesa Biotech (EDSA) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Enterprise Value to EBITDA Ratio iBio Inc|Enterprise Value to EBITDA Ratio CARM|EV/EBITDA Multiple XTL Bio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bolt Biotherapeutics (BOLT)|hcwbiologics.com - Enterprise Value to Operating Income Before Depreciation|EV/EBITDA Multiple APVO (Aptevo Therapeutics Inc.)|aimimmuno.com (AIM) - Company Value to EBITDA|ADTX - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Company Value to Operating Income Before Depreciation Ratio GRI|XORTX Therapeutics Inc. (XRTX) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|reshapelifesciences.com - Business Value to Operating Income Before Depreciation|REVB (Revelation Biosciences, Inc.) - EV/EBITDA Multiple|Company Value to EBITDA Indaptus Therapeutics Inc INDP|EV/EBITDA Multiple SCNI|Enterprise Value to EBITDA Ratio calcimedica.com CALI|EV/EBITDA Multiple AFMD (Affimed N.V.)|Total Company Value to Operating Income Before Depreciation Ratio Allakos Inc (ALLK)|HOOKIPA - EV/EBITDA Multiple|Enterprise Value to EBITDA Multiple IGM Biosciences, Inc. (IGMS)|ITOS: EV/EBITDA Multiple|Company Value to EBITDA Ocean Biomedical Corp (OCEA)|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization TC Biopharm|Enterprise Value to Operating Income Before Depreciation THRD (thirdharmonicbio.com)
